Detalhe da pesquisa
1.
NIS2+TM as a screening tool to optimize patient selection in metabolic dysfunction-associated steatohepatitis clinical trials.
J Hepatol
; 80(2): 209-219, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061448